Acquiring Company
argenx
Acquired Company
Forte Biosciences
Amsterdam
Los AngelesBiotechnologyHealth CareTherapeuticsBiotechnologyHealth CareTherapeuticsDescription
On August 27, 2026, argenx completed its acquisition of Forte Biosciences at a price of USD 77.00 per share. This transaction resulted in Forte becoming a wholly owned subsidiary of argenx, facilitating its exit from Nasdaq. The acquisition involved 87.13 percent of Forte's shares being tendered, marking a significant strategic consolidation in the biotechnology sector.
Fundz sees it the moment argenx makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Forte Biosciences?
Forte Biosciences was acquired by argenx, based in Amsterdam. The deal was reported on October 1, 2026. argenx is a global immunology innovation company focused on developing therapies for patients with severe autoimmune diseases. argenx is publicly traded (ARGX) and operates in Biotechnology.
When did argenx acquire Forte Biosciences?
argenx's acquisition of Forte Biosciences was reported on October 1, 2026. On August 27, 2026, argenx completed its acquisition of Forte Biosciences at a price of USD 77.00 per share. This transaction resulted in Forte becoming a wholly owned subsidiary of argenx, facilitating its exit from Nasdaq. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Forte Biosciences do?
Forte Biosciences, Inc. is a biotechnology company that focuses on developing treatments for autoimmune and inflammatory diseases. The company specializes in its anti-CD122 antibody, FG102, aiming to improve patient quality of life. It is privately held, operating in Biotechnology, and is based in Los Angeles.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.